Sign up online today & collaborate
or click here to find out more
CVS Health Corp, the second-largest manager of drug benefit plans for U.S. employers and insurers, asked heart specialists on Monday to revamp guidelines for treating patients with high cholesterol after the launch of new, expensive medications.
The unusual move is the latest salvo in the war on escalating U.S. healthcare costs, with insurers using aggressive tactics to extract steep price discounts from drugmakers, even for the newest medications, and controlling patient access to the most expensive drugs.
CVS, in a letter published in the latest edition of the Journal of the American Medical Association, said current guidelines, which include a formula for assessing heart disease risk rather than specific targets for levels of "bad" LDL cholesterol, do not provide clarity on how to choose the best, and most cost effective, therapy.For more click here